Adrian F. Ochsenbein

Bern, BE, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14).

Extracellular vesicles as prognostic biomarkers: results of a neoadjuvant chemoimmunotherapy clinical trial in stage IIIA (N2) non-small-cell lung cancer (SAKK 16/14).

Journal: Frontiers in immunology
Published: February 09, 2026

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

CD70/CD27 signaling promotes the pathogenesis of multiple myeloma and represents a promising therapeutic target.

Journal: Leukemia
Published: August 12, 2025

High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression.

High-dimensional spatiotemporal single-cell atlas and 3D imaging of the bone marrow microenvironment during CML progression.

Journal: Blood
Published: May 09, 2025

High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML Progression.

High-Dimensional Spatiotemporal Single-Cell Atlas and 3D imaging of Bone Marrow Microenvironment during CML Progression.

Journal: Blood
Published: May 09, 2025

Immune checkpoints regulate acute myeloid leukemia stem cells.

Immune checkpoints regulate acute myeloid leukemia stem cells.

Journal: Leukemia
Published: November 21, 2024

IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging.

IL-33/ST2 signaling in ILC2s drives exhaustion and myeloid skewing of HSCs in response to hematopoietic stress and aging.

Journal: iScience
Published: July 08, 2024

Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8+ T cell exhaustion in chronic myeloid leukemia.

Intestinal low-abundant bacteria drive MyD88/Trif-dependent CD8+ T cell exhaustion in chronic myeloid leukemia.

Journal: Cell reports
Published: May 21, 2024

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy.

Journal: Nature communications
Published: March 28, 2024

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion.

IL-9 secreted by leukemia stem cells induces Th1-skewed CD4+ T cells, which promote their expansion.

Journal: Blood
Published: February 12, 2024

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

A phase Ib/II randomized, open-label drug repurposing trial of glutamate signaling inhibitors in combination with chemoradiotherapy in patients with newly diagnosed glioblastoma: the GLUGLIO trial protocol.

Journal: BMC cancer
Published: December 09, 2023

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

IL-21/IL-21R signaling renders acute myeloid leukemia stem cells more susceptible to cytarabine treatment and CAR T cell therapy.

Journal: Cell reports. Medicine
Published: September 11, 2023

Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness.

Author Correction: Tumour mutations in long noncoding RNAs enhance cell fitness.

Journal: Nature communications
Published: September 06, 2023
Showing 1-12 of 83

Last Updated: 09/26/2026